AMDL, Inc. Selected as #1 Small-Cap Stock Pick for 2009
December 15 2008 - 9:30AM
PR Newswire (US)
TUSTIN, Calif., Dec. 15 /PRNewswire-FirstCall/ --
(http://www.amdl.com/) AMDL, Inc. (NYSE Alternext US: ADL), a
vertically integrated pharmaceutical company with major operations
in China and the US, announced today it has been selected as Bob
Flaherty's Favorite Stock for 2009 in the December 8 issue of his
online newsletter Flaherty Financial News. "In the most bearish
global market of our lifetime, AMDL should become a standout
winner," commented Editor and Chairman Robert J. Flaherty. "AMDL
has delivered consistent revenue growth in excess of 100% every
quarter for the past 24 months. Under a dynamic new CEO, this
emerging growth stock has an aggressive business plan to expand its
operations from its current 36 cities in China with populations of
over one million to all 168. At its recent depressed stock price
and using guidance forecast for net income ranges, AMDL has a
projected 2009 Price/Earnings ratio of about ONE versus projected
revenues and net income growth of over 100%. This is an outstanding
bargain growth investors definitely should take a close look at."
Mr. Douglas MacLellan, Chairman and CEO of AMDL commented, "As an
emerging growth, high-value small-cap Company we are very focused
on getting our story out to the broad investor community. Being
recognized in this manner is an excellent example of the increased
attention AMDL is receiving. We are extremely honored to be
selected as the #1 stock pick in 2009 by Flaherty Financial News --
an independent, non-sponsored financial newsletter that came to its
decision by comparing the public research including the projected
Price/Earnings ratio of AMDL with a broad range of other large,
mid, small and micro-cap companies." Robert Flaherty is a respected
and well-known financial writer. Decades ago he launched the Forbes
"If you Could Love Only One" segment where famous Wall Street
professionals picked their top favorite stock picks for the
upcoming year to provide investors with educated insight on highly
opportunistic investment opportunities. Flaherty continued the
feature until he retired. He was among the portfolio of individual
stock pickers for over 25 years and had the best long-run print
record for a feature of this kind anywhere in the world. Many of
Flaherty's personal stock picks produced spectacular gains. The
December 8 issue featuring ADML can be accessed by going to
http://www.flahertyfinancialnews.com/ and clicking on the archive
button. For additional information on AMDL and its portfolio of
pharmaceutical products visit http://www.amdl.com/ or contact AMDL
Investor Relations at or 206.310.5323. About AMDL: Headquartered in
Tustin, CA with operations in Shenzhen, Jiangxi, and Jilin, China,
AMDL, Inc., along with its subsidiary Jade Pharmaceutical Inc.
(JPI), is a vertically integrated bio-pharmaceutical company
devoted to the research, development, manufacturing, and marketing
of diagnostic, pharmaceutical, nutritional supplement, and cosmetic
products. The Company employs approximately 500 people in the U.S.
and China. About Flaherty Financial News: Flaherty Financial News
is the publisher of totally-electronic coverage of the neglected
micro and small-cap markets with Flaherty Financial News Newsletter
and Flaherty Special Situations. To opt in for future issues please
visit http://www.flahertyfinancialnews.com/ and log in. Both were
recently launched by the "legendary financial editor" Bob Flaherty,
Editor and Chairman of Flaherty Financial News Inc., and his son
Brian, who serves as President and Publisher. While previously
serving as Chairman and Editor of Equities Magazine for 25 years
until it was sold in September 2006, Bob was also Editor-in-Chief
of Equities Special Situations, which had one of the most
consistent and highest ranked long-run records measured by Hulbert
Financial. Previously, he was an award-winning Senior Editor at
Forbes Magazine, where he wrote 33 cover stories, two shy of the
all time record. He was also Chairman of The Over-The-Counter
Securities Fund. Bob Flaherty is a Magna Cum Laude graduate of
Harvard College in economics and also has an MBA with a Distinction
in Finance from Harvard Business School. Forward Looking
Statements: Safe Harbor Statement under the Private Securities
Litigation Reform Act of 1995: The statements contained in this
document include certain predictions and projections that may be
considered forward-looking statements under securities law. These
statements involve a number of important risks and uncertainties
that could cause actual results to differ materially including, but
not limited to, the performance of our China-based subsidiaries, as
well as other economic, competitive and technological factors
involving the Company's operations, markets, services, products,
and prices. With respect to AMDL Inc., except for the historical
information contained herein, the matters discussed in this
document are forward-looking statements involving risks and
uncertainties that could cause actual results to differ materially
from those in such forward-looking statements. The Company cautions
readers not to place undue reliance on any forward-looking
statements. The Company does not undertake, and specifically
disclaims any obligation, to update or revise such statements to
reflect new circumstances or unanticipated events as they occur.
AMDL Contact: Kristine Szarkowitz Director-Investor Relations (M)
(206) 310-5323 DATASOURCE: AMDL, Inc. CONTACT: Kristine Szarkowitz,
Director-Investor Relations of AMDL, Inc., +1-206-310-5323, Web
site: http://www.amdl.com/ http://www.flahertyfinancialnews.com/
Copyright